Information Technology and Medical Missteps: Evidence from a Randomized Trial

The technology we analyze is the property of Active Health Management, Inc. Dr. Reisman was, and continues to be, the CEO of Active Health. At the time of the study Dr. Javitt was a shareholder and had a consulting relationship with the company. Rebitzer has no financial relationship or proprietary interest in the company. We would like to thank the following for help and advice: Jeffery Jacques, Iver Juster, Jonathan Kay, Mayur Shah, Stephen Rosenberg, Todd Locke, Jim Couch, JB Silvers, Randy Cebul, Mark Votruba and seminar participants at: the Kellogg School at Northwestern University, MIT, The Wharton School at the University of Pennsylvania, Princeton University, the University of Minnesota, the University of Illinois at Urbana, the University of Washington, the Ohlin School at Washington University in St., Louis, the NBER, the Center for Health Care Research and Policy at Case Western Reserve, and the Harvard/BU/MIT Health Economics Seminar. The authors are responsible for any remaining errors. The views expressed herein are those of the author(s) and do not necessarily reflect the views of the National Bureau of Economic Research.